Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Mammalian Cell Fermentation Technology Market to reach USD 76.63 billion by the end of 2030

Global Mammalian Cell Fermentation Technology Market Size Study & Forecast, by Type (Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation, Others), By Application (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes and Others), By End-use (Biopharmaceutical Companies, CMOs & CDMOs, Academic & Research Institutes) and Regional Analysis, 2023-2030

Product Code: HLSB-63628034
Publish Date: 20-10-2023
Page: 200

Global Mammalian Cell Fermentation Technology Market is valued at approximately USD 39.49 billion in 2022 and is anticipated to grow with a growth rate of more than 8.64% over the forecast period 2023-2030. Mammalian cell fermentation, is widely used to create a variety of biosimilars, enzymes, vaccines, and other biologics. It is an essential step in the development of biopharmaceuticals. Mammalian cells are cultured in a bioreactor for fermentation after being produced in vitro from stem cells. The essential byproducts are produced during this process by the cells using a variety of metabolic pathways. The market for Mammalian Cell Fermentation Technology is driven due to factors such as growing prevalence of chronic diseases, growing need for novel and secure therapies and the growing demand for biologics and biosimilars.

Additionally, the rising prevalence of various chronic diseases including cancer is driving the market growth as cancer treatment often involves the use of biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. Mammalian cell fermentation is a crucial method for producing these complex biologics. The demand for biologics rises due to the rising prevalence of cancer, which, in turn, drives the need for mammalian cell fermentation technology. According to the International Agency for Research on Cancer (IARC), it is estimated that there was an increase in the global burden of cancer in 2021 approximately 1.9 million new cases have been recorded, which is projected to account for 27.5 million new cases by 2040. Thus, this factor is propelling the demand for the development of personalized medicines, resulting in market growth, The demand for biologics and biosimilars is driving the market for mammalian cell fermentation technology. These therapies are essential for addressing a number of disorders, such as cancer, autoimmune diseases, and various chronic diseases. In May 2022, Biocon Biologics Ltd. and Viatris Inc. received approval from Health Canada for Abevmy (bevacizumab), a biosimilar to Roche’s Avastin (bevacizumab), across four cancer indications. Consequentially, the rising development of biologics and biosimilars is driving market growth. Furthermore, rising technological advancement, as well as the increasing research and development spending by pharmaceutical companies are creating new opportunities to the market. However, the high cost associated with the development of technology is restraining the market growth in the forecast period 2023-2030.

The key regions considered for the Global Mammalian Cell Fermentation Technology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the region’s strong biopharmaceutical industry presence, supportive government regulations, and well-developed healthcare infrastructure. Additionally, the increased demand for biologics and biosimilars as well as the rising prevalence of chronic diseases have contributed to the expansion of the market in the region. Asia Pacific is expected to a fastest growing region during the forecast period, owing to factors such as a big patient population, increasing demand for biologic pharmaceuticals, government initiatives to support biotechnology research and development, and a growth in contract manufacturing organizations (CMOs) in the region, are driving this expansion.

Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KGaA
Danaher Corporation
Lonza Group
Hoffmann-La Roche Ltd
Sartorius AG
AstraZeneca
Bristol-Myers Squibb
Amgen Inc.
Gilead Sciences Inc.

Recent Developments in the Market:
Ø In January 2023, Fosun Pharma and Shanghai Henlius Biotech announced their agreement for the marketing of serplulimab, an anti-PD-1 monoclonal antibody . The agreement is anticipated to broaden Fosun Pharma’s biologics portfolio, as well as its manufacturing and development capabilities, in this quickly expanding market.

Global Mammalian Cell Fermentation Technology Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Application, End Use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Hamster Ovary (CHO) Cell Fermentation
Human Embryonic Kidney (HEK) Cell Fermentation
Baby Hamster Kidney (BHK) Cell Fermentation
Murine Myeloma Cell Fermentation
Others

By Application:
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Hormones
Enzymes
Others

By End Use:
Biopharmaceutical Companies
CMOs & CDMOs
Academic & Research Institutes

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Mammalian Cell Fermentation Technology Market, by region, 2020-2030 (USD Billion)
1.2.2. Mammalian Cell Fermentation Technology Market, by Type, 2020-2030 (USD Billion)
1.2.3. Mammalian Cell Fermentation Technology Market, by Application, 2020-2030 (USD Billion)
1.2.4. Mammalian Cell Fermentation Technology Market, by End Use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Mammalian Cell Fermentation Technology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Mammalian Cell Fermentation Technology Market Dynamics
3.1. Mammalian Cell Fermentation Technology Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of chronic diseases
3.1.1.2. Increasing need for novel and secure therapies
3.1.1.3. Growing demand for biologics and biosimilars
3.1.2. Market Challenges
3.1.2.1. High cost of mammalian cell fermentation technology
3.1.2.2. Stringent government regulations
3.1.3. Market Opportunities
3.1.3.1. Technological advancement
3.1.3.2. Increasing research and development spending
Chapter 4. Global Mammalian Cell Fermentation Technology Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Mammalian Cell Fermentation Technology Market, by Type
5.1. Market Snapshot
5.2. Global Mammalian Cell Fermentation Technology Market by Type, Performance – Potential Analysis
5.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
5.4.1. Hamster Ovary (CHO) Cell Fermentation
5.4.2. Human Embryonic Kidney (HEK) Cell Fermentation
5.4.3. Baby Hamster Kidney (BHK) Cell Fermentation
5.4.4. Murine Myeloma Cell Fermentation
5.4.5. Others
Chapter 6. Global Mammalian Cell Fermentation Technology Market, by Application
6.1. Market Snapshot
6.2. Global Mammalian Cell Fermentation Technology Market by Application, Performance – Potential Analysis
6.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Recombinant Proteins
6.4.3. Vaccines
6.4.4. Hormones
6.4.5. Enzymes
6.4.6. Others
Chapter 7. Global Mammalian Cell Fermentation Technology Market, by End Use
7.1. Market Snapshot
7.2. Global Mammalian Cell Fermentation Technology Market by End Use, Performance – Potential Analysis
7.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
7.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
7.4.1. Biopharmaceutical Companies
7.4.2. CMOs & CDMOs
7.4.3. Academic & Research Institutes
Chapter 8. Global Mammalian Cell Fermentation Technology Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Mammalian Cell Fermentation Technology Market, Regional Market Snapshot
8.4. North America Mammalian Cell Fermentation Technology Market
8.4.1. U.S. Mammalian Cell Fermentation Technology Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Mammalian Cell Fermentation Technology Market
8.5. Europe Mammalian Cell Fermentation Technology Market Snapshot
8.5.1. U.K. Mammalian Cell Fermentation Technology Market
8.5.2. Germany Mammalian Cell Fermentation Technology Market
8.5.3. France Mammalian Cell Fermentation Technology Market
8.5.4. Spain Mammalian Cell Fermentation Technology Market
8.5.5. Italy Mammalian Cell Fermentation Technology Market
8.5.6. Rest of Europe Mammalian Cell Fermentation Technology Market
8.6. Asia-Pacific Mammalian Cell Fermentation Technology Market Snapshot
8.6.1. China Mammalian Cell Fermentation Technology Market
8.6.2. India Mammalian Cell Fermentation Technology Market
8.6.3. Japan Mammalian Cell Fermentation Technology Market
8.6.4. Australia Mammalian Cell Fermentation Technology Market
8.6.5. South Korea Mammalian Cell Fermentation Technology Market
8.6.6. Rest of Asia Pacific Mammalian Cell Fermentation Technology Market
8.7. Latin America Mammalian Cell Fermentation Technology Market Snapshot
8.7.1. Brazil Mammalian Cell Fermentation Technology Market
8.7.2. Mexico Mammalian Cell Fermentation Technology Market
8.8. Middle East & Africa Mammalian Cell Fermentation Technology Market
8.8.1. Saudi Arabia Mammalian Cell Fermentation Technology Market
8.8.2. South Africa Mammalian Cell Fermentation Technology Market
8.8.3. Rest of Middle East & Africa Mammalian Cell Fermentation Technology Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Thermo Fisher Scientific, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Merck KGaA
9.3.3. Danaher Corporation
9.3.4. Lonza Group
9.3.5. Hoffmann-La Roche Ltd
9.3.6. Sartorius AG
9.3.7. AstraZeneca
9.3.8. Bristol-Myers Squibb
9.3.9. Amgen Inc.
9.3.10. Gilead Sciences Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now